Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2025-08-15 00:00:00 ET · period of report 2025-08-13 · accession 0001415889-25-022069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-15 | 2025-08-13 | CLDX | Jimenez Freddy A. | SVP, GC | S - Sale | $24.77 | -771 | 35.0K | -2% | -$19.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-13 | S | D | 341 | $23.95 | 35,392 | D | — | — | (F1) Includes 269 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-08-13 | S | D | 430 | $25.42 | 34,962 | D | — | — |